QS Investors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-295
Closed -$207K 1195
2020
Q3
$207K Sell
295
-778
-73% -$607K ﹤0.01% 1068
2020
Q2
$849K Buy
1,073
+973
+973% +$734K 0.01% 768
2020
Q1
$60K Buy
100
+7
+8% +$6.82K ﹤0.01% 1375
2019
Q4
$104K Hold
93
﹤0.01% 1374
2019
Q3
$111K Hold
93
﹤0.01% 1359
2019
Q2
$153K Hold
93
﹤0.01% 1279
2019
Q1
$189K Hold
93
﹤0.01% 1240
2018
Q4
$120K Hold
93
﹤0.01% 1277
2018
Q3
$176K Sell
93
-527
-85% -$1.09M ﹤0.01% 1237
2018
Q2
$1.26M Hold
620
0.01% 728
2018
Q1
$1.37M Buy
620
+527
+567% +$1.34M 0.01% 698
2017
Q4
$214K Hold
93
﹤0.01% 1181
2017
Q3
$166K Hold
93
﹤0.01% 1296
2017
Q2
$127K Buy
93
+38
+69% +$45.9K ﹤0.01% 1352
2017
Q1
$64K Buy
55
+54
+5,400% +$55.1K ﹤0.01% 1456
2016
Q4
$1K Hold
1
﹤0.01% 1544
2016
Q3
$1K Hold
1
﹤0.01% 1531
2016
Q2
$1K Buy
+1
New +$566 ﹤0.01% 1555
2016
Q1
Hold
0
-$1K 1986
2015
Q4
Hold
0
1565

Other funds holding BLUE

QS Investors's BLUE Position: Q4 2020 in Review

QS Investors sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 295 shares — an estimated $207K sold.

QS Investors first reported a position in BLUE in Q2 2016 and held it in 18 quarters. The position peaked at $1.37M in Q1 2018. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • QS Investors reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • QS Investors sold 295 bluebird bio shares in Q4 2020, an estimated $207K.
  • QS Investors first reported a position in bluebird bio in Q2 2016 and held it in 18 quarters.
  • QS Investors's bluebird bio position peaked at $1.37M in Q1 2018.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.